Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, ...

Vincerx Pharma (VINC) announced plans to implement cost-controls and explore strategic alternatives to support advancing the Phase 1 study of VIP943, the company’s novel CD123-targeted antibody ...

UFC Lightweight and The Ultimate Fighter (TUF) season 15 veteran Vinc Pichel announced his retirement from mixed martial arts (MMA) at age 42 earlier this afternoon.

A high-level overview of Vincerx Pharma, Inc. (VINC) stock. View (VINC) real-time stock price, chart, news, analysis, analyst reviews and more.

Vincerx Pharma Inc VINC shares are trading lower by 9.7% to $0.81 during Friday’s session after the company priced an underwritten public offering, including 6 million shares of common stock ...

The current price Vincerx Pharma (VINC) is trading at is $0.05, which is out of the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Connect With Us ...